- $4.37bn
- $5.28bn
- $2.72bn
Annual income statement for Belden, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,301 | 2,606 | 2,512 | 2,461 | 2,715 |
| Cost of Revenue | |||||
| Gross Profit | 780 | 926 | 957 | 924 | 1,032 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,043 | 2,250 | 2,195 | 2,195 | 2,400 |
| Operating Profit | 258 | 357 | 318 | 266 | 316 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 227 | 317 | 286 | 228 | 267 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 199 | 268 | 243 | 198 | 238 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 63.9 | 255 | 243 | 198 | 238 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 63.9 | 255 | 243 | 198 | 238 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.92 | 5.87 | 6.05 | 5.39 | 6.26 |
| Dividends per Share |